Chief Physician
Surgical treatment of gynecological benign and malignant tumors such as cervical cancer, endometrial cancer, ovarian cancer, uterine fibroids, ovarian cancer, endometriosis, uterine prolapse, uterine adhesions and other diseases, has rich experience in chemotherapy, targeted therapy and immunotherapy of gynecological malignant tumors such as cervical cancer, endometrial cancer, ovarian cancer, vulvar cancer, etc. has performed over 10,000 laparotomy and minimally invasive laparoscopic, hysteroscopic and vaginal surgeries.
Chief Physician of Gynecology Clinic, from Hunan Province, graduated from Nanchang University, has been engaged in obstetrics and gynecology clinical work for more than 30 years after graduation, has gone to Xiangya Hospital of Central South University, Obstetrics and Gynecology Department of Peking Union Medical College Hospital, Wayne State University in the United States to study for further education.
Mainly good at: Surgical treatment of gynecological benign and malignant tumors such as cervical cancer, endometrial cancer, ovarian cancer, uterine fibroids, ovarian cancer, endometriosis, uterine prolapse, uterine adhesions and other diseases, has rich experience in chemotherapy, targeted therapy and immunotherapy of gynecological malignant tumors such as cervical cancer, endometrial cancer, ovarian cancer, vulvar cancer, etc. has performed over 10,000 laparotomy and minimally invasive laparoscopic, hysteroscopic and vaginal surgeries.
Experimental study on fertility preservation operation for ovarian epithelial carcinoma
Standing member of the Obstetricians and Gynecologists Branch of Hainan Provincial Physicians Association
Standing member of Minimally Invasive Gynecology Specialized Committee of Hainan Medical Association
Standing member of Cervical Cancer Prevention and Treatment Specialized Committee of Hainan Maternal and Child Health Association
Member of the Sixth Committee of Medical Genetics Branch of Hainan Medical Association
Member of Maternal-Fetal Medicine Group, Obstetricians and Gynecologists Branch, Hainan Provincial Physicians Association
1.Expression and Clinical Significance of Ubiquitin-specific Protease I and Karyopherin a-2 in Endometriosis Patients, China Journal of Eugenics and Genetics, Volume 30, 2022.
2.Study on the Mechanism of Regulation of Proliferation and Apoptosis of Cervical Cancer Cells by Targeting mid-506-5P with Inc RNA FOXD2-ASI", Chinese Journal of Cancer Biotherapy, Vol. 26, Issue 10.
3.2020 Research Project of Hainan Provincial Health Department (in progress): Study on the Application of Low Molecular Weight Heparin Sodium in Patients with Recurrent Abortion.
4.Also participated in the ongoing national multicenter clinical studies, including Multicenter Screening and Early Diagnosis of Endometrial Cancer in High Risk Groups and Study of Cervical Cytology DNA Early Basification for Endometrial Cancer Screening.
